Literature DB >> 23839843

Successful use of inhaled nitric oxide for severe hypoxemia in an infant with acute exacerbation of bronchiolitis due to sepsis.

K Okamoto1, T Tashima, I Kukita, T Sato, M Kurose, K Taki.   

Abstract

Entities:  

Year:  1995        PMID: 23839843     DOI: 10.1007/BF02482044

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


× No keyword cloud information.
  9 in total

1.  Safety guidelines for use of nitric oxide.

Authors:  L Foubert; B Fleming; R Latimer; M Jonas; A Oduro; C Borland; T Higenbottam
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

2.  Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.

Authors:  C Frostell; M D Fratacci; J C Wain; R Jones; W M Zapol
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

3.  Bronchodilator action of inhaled nitric oxide in guinea pigs.

Authors:  P M Dupuy; S A Shore; J M Drazen; C Frostell; W A Hill; W M Zapol
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

4.  Nitrosyl-hemoglobin formation in the blood of animals exposed to nitric oxide.

Authors:  H Oda; S Kusumoto; T Nakajima
Journal:  Arch Environ Health       Date:  1975-09

5.  Successful use of inhaled nitric oxide for treatment of severe hypoxemia in an infant with total anomalous pulmonary venous return.

Authors:  K Okamoto; T Sato; M Kurose; I Kukita; H Fujii; K Taki
Journal:  Anesthesiology       Date:  1994-07       Impact factor: 7.892

6.  Inhaled nitric oxide for the adult respiratory distress syndrome.

Authors:  R Rossaint; K J Falke; F López; K Slama; U Pison; W M Zapol
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245

7.  Pulmonary performance of elderly normal subjects and subjects with chronic obstructive pulmonary disease exposed to 0.3 ppm nitrogen dioxide.

Authors:  P E Morrow; M J Utell; M A Bauer; A M Smeglin; M W Frampton; C Cox; D M Speers; F R Gibb
Journal:  Am Rev Respir Dis       Date:  1992-02

8.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

9.  Use of extracorporeal membrane oxygenation in the treatment of respiratory syncytial virus bronchiolitis: the national experience, 1983 to 1988.

Authors:  R H Steinhorn; T P Green
Journal:  J Pediatr       Date:  1990-03       Impact factor: 4.406

  9 in total
  1 in total

1.  Inhaled nitric oxide therapy for severe hypoxemia in hyperinflated mechanically ventilated bronchiolitis patient.

Authors:  Alvaro DonaireGarcia; Rashmitha Dachepally; William Hanna; Samir Q Latifi; Hemant S Agarwal
Journal:  Respir Med Case Rep       Date:  2022-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.